Posts Tagged

Life Reinsurance

In November 2026, Munich Re reported a third quarter life and health reinsurance technical result of EUR 493 million, up from EUR 314 million a year earlier. The company published the segment detail on 12 November for the quarter ended 30 September. It attributed the performance to strong new business and favourable biometric experience, particularly mortality. The segment net result rose to EUR 340 million from EUR 286 million.

In October 2026, Lincoln Financial announced completion of its USD 6.3 billion reinsurance transaction with Talcott Financial Group, effective on 1 October. Approximately USD 5.8 billion of guaranteed universal life statutory reserves were ceded to a Talcott subsidiary. Including an earlier Fortitude Re transaction, about 60 per cent of Lincoln’s total guaranteed universal life block is now reinsured. Lincoln continues administering the policies. The deal concerns individual life business

In September 2026, Pacific Life Re announced the appointment of Mei Sum Chan as Head of Medical Analytics, succeeding Ian Collins on his retirement. The 25 September report says Collins had built and led the function and that Chan had most recently advised research and development and global divisions on health and statistics. The reinsurer describes the team’s purpose as understanding emerging health and mortality trends, supporting assumption development

In a recent report by AM Best, titled “Life/Annuity Reinsurers Remain Prepared for Growth,” global life reinsurers are seen weathering the storm of excess mortality with cautious optimism. Despite facing challenges due to elevated life claims, the industry appears poised for continued growth. The report, part of AM Best’s comprehensive analysis of the global reinsurance industry leading up to the Rendez-Vous de Septembre in Monte Carlo, highlights several key